TMC Life Sciences Bhd (0101) - Total Assets
Based on the latest financial reports, TMC Life Sciences Bhd (0101) holds total assets worth RM1.12 Billion MYR (≈ $280.98 Million USD) as of November 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See TMC Life Sciences Bhd (0101) shareholders funds for net asset value and shareholders' equity analysis.
TMC Life Sciences Bhd - Total Assets Trend (2006–2025)
This chart illustrates how TMC Life Sciences Bhd's total assets have evolved over time, based on quarterly financial data.
TMC Life Sciences Bhd - Asset Composition Analysis
Current Asset Composition (August 2025)
TMC Life Sciences Bhd's total assets of RM1.12 Billion consist of 17.9% current assets and 82.1% non-current assets.
| Asset Category | Amount (MYR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM66.01 Million | 9.3% |
| Accounts Receivable | RM60.18 Million | 5.3% |
| Inventory | RM15.91 Million | 1.4% |
| Property, Plant & Equipment | RM725.78 Million | 64.1% |
| Intangible Assets | RM8.15 Million | 0.7% |
| Goodwill | RM193.04 Million | 17.1% |
Asset Composition Trend (2006–2025)
This chart illustrates how TMC Life Sciences Bhd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see TMC Life Sciences Bhd market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: TMC Life Sciences Bhd's current assets represent 17.9% of total assets in 2025, a decrease from 22.5% in 2006.
- Cash Position: Cash and equivalents constituted 9.3% of total assets in 2025, down from 19.6% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 12.0% in 2006.
- Asset Diversification: The largest asset category is property, plant & equipment at 64.1% of total assets.
TMC Life Sciences Bhd Competitors by Total Assets
Key competitors of TMC Life Sciences Bhd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fresenius Medical Care AG & Co. KGaA
XETRA:FME
|
Germany | €31.47 Billion |
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$21.70 Billion |
|
Huaxia Eye Hospital Group Co. Ltd. A
SHE:301267
|
China | CN¥8.17 Billion |
|
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA
|
Indonesia | Rp9.64 Trillion |
|
MLP Saglik Hizmetleri AS
IS:MPARK
|
Turkey | TL89.94 Billion |
|
VITA 34 AG
XETRA:V3V
|
Germany | €168.26 Million |
|
P3 Health Partners Inc
NASDAQ:PIII
|
USA | $683.56 Million |
|
Bumrungrad Hospital Public Company Limited
F:BZ7A
|
Germany | €36.46 Billion |
TMC Life Sciences Bhd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.87 | 1.99 | 2.62 |
| Quick Ratio | 1.71 | 1.87 | 2.48 |
| Cash Ratio | 1.05 | 0.00 | 0.00 |
| Working Capital | RM93.75 Million | RM105.56 Million | RM109.61 Million |
TMC Life Sciences Bhd - Advanced Valuation Insights
This section examines the relationship between TMC Life Sciences Bhd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.01 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | -4.8% |
| Total Assets | RM1.13 Billion |
| Market Capitalization | $207.73 Million USD |
Valuation Analysis
Below Book Valuation: The market values TMC Life Sciences Bhd's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: TMC Life Sciences Bhd's assets decreased by 4.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for TMC Life Sciences Bhd (2006–2025)
The table below shows the annual total assets of TMC Life Sciences Bhd from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-08-31 | RM1.13 Billion ≈ $284.26 Million |
-4.84% |
| 2024-08-31 | RM1.19 Billion ≈ $298.70 Million |
+1.10% |
| 2023-08-31 | RM1.18 Billion ≈ $295.45 Million |
+3.88% |
| 2022-08-31 | RM1.13 Billion ≈ $284.42 Million |
+6.85% |
| 2021-08-31 | RM1.06 Billion ≈ $266.19 Million |
+11.55% |
| 2020-08-31 | RM950.44 Million ≈ $238.62 Million |
+12.01% |
| 2019-08-31 | RM848.52 Million ≈ $213.03 Million |
+5.82% |
| 2018-08-31 | RM801.84 Million ≈ $201.32 Million |
+4.20% |
| 2017-08-31 | RM769.52 Million ≈ $193.20 Million |
+9.97% |
| 2016-08-31 | RM699.78 Million ≈ $175.69 Million |
+106.01% |
| 2015-08-31 | RM339.69 Million ≈ $85.28 Million |
+106.45% |
| 2014-08-31 | RM164.53 Million ≈ $41.31 Million |
+5.15% |
| 2013-08-31 | RM156.48 Million ≈ $39.29 Million |
+1.75% |
| 2012-08-31 | RM153.79 Million ≈ $38.61 Million |
+5.48% |
| 2011-08-31 | RM145.81 Million ≈ $36.61 Million |
-16.08% |
| 2009-08-31 | RM173.75 Million ≈ $43.62 Million |
+2.46% |
| 2008-08-31 | RM169.59 Million ≈ $42.58 Million |
+80.09% |
| 2007-08-31 | RM94.17 Million ≈ $23.64 Million |
+55.26% |
| 2006-08-31 | RM60.65 Million ≈ $15.23 Million |
-- |
About TMC Life Sciences Bhd
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; propert… Read more